2. Academic Validation
  3. Modern phenotypic drug discovery is a viable, neoclassic pharma strategy

Modern phenotypic drug discovery is a viable, neoclassic pharma strategy

  • J Med Chem. 2012 May 24;55(10):4527-38. doi: 10.1021/jm201649s.
Jonathan A Lee 1,  Mark T Uhlik,  Christopher M Moxham,  Dirk Tomandl,  Daniel J Sall
Affiliations

Affiliation

  • 1 Department of Quantitative Biology, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA. jonathan_a_lee@lilly.com
PMID: 22409666 DOI: 10.1021/jm201649s
Figures